Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 10
2019 14
2020 8
2021 8
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
Muehlematter UJ, Schweiger L, Ferraro DA, Hermanns T, Maurer T, Heck MM, Rupp NJ, Eiber M, Rauscher I, Burger IA. Muehlematter UJ, et al. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3137-3146. doi: 10.1007/s00259-023-06278-1. Epub 2023 Jun 1. Eur J Nucl Med Mol Imaging. 2023. PMID: 37261472 Free PMC article.
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study.
Christ SM, Pohl K, Muehlematter UJ, Heesen P, Kühnis A, Willmann J, Ahmadsei M, Badra EV, Kroeze SGC, Mayinger M, Andratschke N, Huellner M, Guckenberger M. Christ SM, et al. Among authors: muehlematter uj. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):596-602. doi: 10.1016/j.ijrobp.2022.06.100. Epub 2022 Jul 28. Int J Radiat Oncol Biol Phys. 2022. PMID: 35908582
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.
Christ SM, Heesen P, Muehlematter UJ, Pohl K, William Thiel G, Willmann J, Ahmadsei M, Kroese TE, Mayinger M, Balermpas P, Wicki A, Andratschke N, Huellner M, Guckenberger M. Christ SM, et al. Among authors: muehlematter uj. Clin Transl Radiat Oncol. 2022 Nov 15;38:123-129. doi: 10.1016/j.ctro.2022.11.008. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36420098 Free PMC article.
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors.
Schneider MA, Linecker M, Fritsch R, Muehlematter UJ, Stocker D, Pestalozzi B, Samaras P, Jetter A, Kron P, Petrowsky H, Nicolau C, Lehn JM, Humar B, Graf R, Clavien PA, Limani P. Schneider MA, et al. Among authors: muehlematter uj. Nat Commun. 2021 Jun 21;12(1):3807. doi: 10.1038/s41467-021-24069-w. Nat Commun. 2021. PMID: 34155211 Free PMC article. Clinical Trial.
42 results